Brief: Brain AG FY Adjusted EBITDA Loss Narrows To EUR 2.0 Million

BRAIN Biotech AG

14/01/2021 07:03

Jan 14 (Reuters) - BRAIN Biotechnology Research and
Information Network AG  BNNn.DE :
    * REPORTED 3.4% ORGANIC REVENUE GROWTH DESPITE CHALLENGING
ECONOMIC ENVIRONMENT LEADING TO CONSOLIDATED REVENUES OF EUR
38.2 MILLION IN PAST FINANCIAL YEAR.
    * TOTAL OPERATING PERFORMANCE IN REPORTING PERIOD FROM
OCTOBER
1ST, 2019 TO SEPTEMBER 30TH, 2020 HAS BEEN AT EUR 39.2 MILLION.
    * ADJUSTED EBITDA SLIGHTLY IMPROVED FROM EUR -2.2 MILLION IN
PREVIOUS YEAR TO EUR -2.0 MILLION DUE TO AN IMPROVED MATERIAL
EXPENSE RATIO.

Source text for Eikon:  ID:nEQ6Cw79pa 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))